The PGC-II Polymorphism of the Peroxisome Proliferator-activated Receptor ${\gamma}$ Coactivator $1{\alpha}$ (PGC-$1{\alpha}$) Gene in Korean Subjects with the Metabolic Syndrome

  • Im, Sun-Ok (Chungmu Hospital) ;
  • Kim, In-Sik (Department of Biomedical Laboratory Science, School of Medicine Eulji University) ;
  • Kang, Sang-Sun (Department of Biology Education, Chungbuk National University) ;
  • Hyun, Sung-Hee (Department of Biomedical Laboratory Science, School of Medicine Eulji University)
  • Received : 2012.12.19
  • Accepted : 2012.06.04
  • Published : 2012.06.30

Abstract

RFLP of PGC-$1{\alpha}$ gene of 285 Korean women was analyzed by PCR and HpaII restriction. We evaluated the correlation between PGC 1 genotypes and biochemical results, using the results of RFLP. Study subjects were divided into 3 groups: normal group (who has been average value of serum biochemical analysis), upper group (who has been higher value than average value), and low group (who have been lower value than average value). The frequencies of $H_1H_1$, $H_1H_2$, and $H_2H_2$ genotypes were 92 (32%), 85 (32%), and 108 (38%) respectively, and the ratio between $H_1$ and $H_2$ alleles was 1:1.1. There were no meaningful differences between biochemical results and PGC-$1{\alpha}$ genotypes in the normal group. But, in upper group, there was significant difference in total cholesterol (P=0.04) level. In the result of Turkey multiple comparison test, the P value of $H_1H_1$ and $H_2H_2$ was 0.059. In upper group, there were noticeable differences also in triglyceride (P=0.034) level and glucose (P=0.043) level, respectively. There were important differences between $H_1H_1$ type and $H_1H_2$ type in triglyceride (P=0.029) level and between $H_1H_2$ type and $H_2H_2$ type in glucose (P=0.040) level. This study may provide the PGC-$1{\alpha}$ genotype patterns for the amounts of lipid and glucose in the serum. $H_2$ allele (Ser482) of PGC-$1{\alpha}$ gene may be related with upper group in Korean women.

Keywords

References

  1. Abel ED, Peroni O, Kim JK, Kim YB, boss O, Hadro E, Minnemann T, Shulamn GI, Kahn BB. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature. 2001. 409: 729-733. https://doi.org/10.1038/35055575
  2. Auboeuf D, Rieusset J, Fajas L, Vallier P, Frering V, Riou JP, Staels B, Auwerx J, Laville M, Vidal H. Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver x receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients. Diabetes. 1997. 48: 1319-1327.
  3. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes. 1997. 46: 3-10. https://doi.org/10.2337/diabetes.46.1.3
  4. Boustead JN, Stadelmaier BT, Eeds AM, Wiebe PO, Svitekca, Oeser JK. Hepatocyte nuclear factor-4 alpha mediates the stimulatory effect of peroxisome proliferators-activated receptor gamma co-activator-1 alpha (PGC-1 alpha) on glucose-6-phosphatase catalytic subunit gene transcription in H4IE cells. Biochem J. 2003. 369: 17-22. https://doi.org/10.1042/BJ20021382
  5. Brady PS, Marrine KA, Brady LJ, Ramsay RR. Co-ordinate induction of hepatic mitochondrial and peroxisomal carnitine acyltransferase synthesis by diet and drugs. Biochem J. 1989. 260: 93-100. https://doi.org/10.1042/bj2600093
  6. Carvalho E, Jansson PA, Nagaev I, Wenthzel AM, Smith U. Insulin resistance with low cellular IRS-I expression is also associated with low GLUT4 expression and impaired insulin stimulated glucose transport. FASEB J. 2001. 15: 1101-1103.
  7. Ek J, Andersen G, Urhammer SA, Hansen L, Carstensen B, Borch- Johnsen K, Drivsholm T, Berglund L, Hansen T, Lithell H, Pedersen O. Studies of the Proe12Ala polymorphism of the peroxisome proliferators-activated receptor-${\gamma}2$ (PPAR-${\gamma}2$) gene in relation to insulin sensitivity among glucose tolerant Caucasians. Diabetologia. 2001. 44: 1170-1176. https://doi.org/10.1007/s001250100629
  8. Goto M, Terada S, Kato M, Katoh M, Yolozeki T, Tabata I, Shimokawa T. cDNA Cloning and mRNA analysis of PGC-1 in epitrochlearis muscle in swimming-exercised rats. Biochem Biophys Res Commun. 2000. 274: 350-354. https://doi.org/10.1006/bbrc.2000.3134
  9. Hammarstedt A, Jansson PA, Wesslau C, Yang X, Smith U. Reduced expression of PGC-1 and insulin-signaling molecules in adipose tissue is associated with insulin resistance. Biochem Biophys Res Commun. 2003. 301: 578-583. https://doi.org/10.1016/S0006-291X(03)00014-7
  10. Hara K, Tobe K, Okdad T, Kadowaki H, Akanuma Y, Ito C, Kimura S, Kadowaki T. A genetic variation in the PGC-1 gene could confer insulin resistance and susceptibility to Type II diabetes. Diabetologia. 2002. 45: 740-743. https://doi.org/10.1007/s00125-002-0803-z
  11. Herzig S, Long F, Jhala US, Hedrick S, Quinn R, Bauer A, Rudolph D, Schutz G, Yoon C, Puigserver P, Spigelman B, Montminy M. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature. 2001. 413: 179-183. https://doi.org/10.1038/35093131
  12. Himms-Hagen J. Brown adipose tissue thermogenesis: inter disciplinary studies. FASEB J. 1990. 4: 2890-2898. https://doi.org/10.1096/fasebj.4.11.2199286
  13. Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferations. Nature. 1990. 347: 645-650. https://doi.org/10.1038/347645a0
  14. Kersten S. Peroxisome proliferator activated receptors and obesity. European J Pharm. 2002. 440: 223-234. https://doi.org/10.1016/S0014-2999(02)01431-0
  15. klover PJ, Mooney RA. Cell in focus. Hepatocytes: critical for glucose homeostasis. Inermational J Biochem Cell Biol. 2004. 36:753-758. https://doi.org/10.1016/j.biocel.2003.10.002
  16. Louise A, Rasmussen S, Fenger M, Jorgensen T, borch-Johnsen K, Madsbad S, Urhammer SA. Studies of the Gly482Ser polymorphism of the peroxisome proliferators-activated receptor $\gamma$ coactivator $1{\alpha}$ (PGC-$1{\alpha}$) gene in Danish subjects with the metabolic syndrome. Diabetes Res Clin Pract. 2005. 67: 175-179. https://doi.org/10.1016/j.diabres.2004.06.013
  17. Park KS, Ciaraldi TP, Abrams-Carter L, Mudaliar S, Nikoulina SE, Henry RR. PPAR $\gamma$ gene expression is elevated in skeletal muscle of obese and Type II diabetic subjects. Diabetes. 1997. 46: 1230-1234. https://doi.org/10.2337/diabetes.46.7.1230
  18. Poulsen P, Anderson G, Fenger M, Hansen T, Echwald SM, Volund Α, Beck-Nielsen H, Pedersen O, Vaag A. Impact of two common polymorphisms in the PPAR-$\gamma$ gene on glucose tolerance and plasma insulin profiles in monozygotic and dizygotic twins: thrifty genotype, thrifty phenotype, or both? Diabetes. 2003. 52: 194-198. https://doi.org/10.2337/diabetes.52.1.194
  19. Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell. 1998. 92: 829-839. https://doi.org/10.1016/S0092-8674(00)81410-5
  20. Puigserver P, Fhee J, Lin J, Wu Z, Yoon JC, Krauss S, Mootha VK, Lowell BB, Spiegelman BM. Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPAR$\gamma$ coactivator-1. Mol Cell. 2001. 8: 971-982. https://doi.org/10.1016/S1097-2765(01)00390-2
  21. Scarpulla RC. Nuclear activators and coactivators in mammalian mitochondrial biogenesis. Biochimica et Biophysica Acta. 2002. 1576: 1-14. https://doi.org/10.1016/S0167-4781(02)00343-3
  22. Yen CJ, Beamer BA, Negri C, Silver K, Brown KA, Yarnall DP, Burns DK, Roth J, Shuldiner AR. Molecular Scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation. Biochem Biophys Res Common. 1997. 241: 270-274. https://doi.org/10.1006/bbrc.1997.7798
  23. Zierath J, Krook Α, Wallberg-Henriksson H. Insulin action and insulin resistance in human skeletal muscle. Diabetologia. 2000. 43: 821-835. https://doi.org/10.1007/s001250051457